Table 2.
Univariate and multivariate analysis for overall survival
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| 5-yr OS | P-value | HR (95% CI) | P-value | |
| Sex (Male vs. Female) | 49% vs. 48% | 0.970 | ||
| Age (≥20 vs. < 20) | 41% vs. 53% | 0.690 | ||
| Stage(I or II vs. III or IV) | 60% vs. 36% | 0.020 | ||
| Histologic Grade (Grade 1 or 2 vs. Grade 3) | 100% vs. 45% | 0.043 | ||
| Tumor location (Axial vs. Extremity) | 42% vs. 52% | 0.389 | ||
| Initial metastasis (Yes vs. No) | 16% vs. 55% | 0.001 | 3.365 (1.295–8.745) | 0.013 |
| Surgery (Yes vs. No) | 50% vs. 0% | 0.045 | ||
| Margin status (R0 vs. R1 or R2) | 59% vs. 32% | 0.036 | ||
| EZH2 (non-high vs. high) | 78% vs. 41% | 0.026 | ||
| SUZ12 (non-high vs. high) | 53% vs. 0% | 0.001 | 29.069 (1.690–500.007) | 0.020 |
| EED1 (non-high vs. high) | 67% vs. 44% | 0.279 | ||
| H3K27me3 (non-high vs. high) | 51% vs. 0% | 0.009 | 3.743 (1.370–10.228) | 0.010 |
| All PRC2 (non-high vs. high) | 52% vs. 0% | 0.009 | ||
HR hazard ratio, CI, confidence interval